Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
Hebaallah Mamdouh Hashiesh, Charu Sharma, Sameer N. Goyal, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 22
Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Neurochemistry International (2024) Vol. 177, pp. 105761-105761
Closed Access | Times Cited: 15
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists
Miroslav Kosar, Roman C. Sarott, David A. Sykes, et al.
ACS Central Science (2024) Vol. 10, Iss. 5, pp. 956-968
Open Access | Times Cited: 8
The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review
Eman A. Alraddadi, Faisal F. Aljuhani, Ghadah Y. Alsamiri, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 9, pp. 1565-1575
Open Access | Times Cited: 30
Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells
Hee‐Seop Lee, Gillian Tamia, Hee-Jung Song, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108865-108865
Closed Access | Times Cited: 26
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands
Francesca Gado, Rebecca Ferrisi, Beatrice Polini, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9918-9938
Open Access | Times Cited: 22
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model
Philipp Spatz, Sophie A. M. Steinmüller, Anna Tutov, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6414-6435
Open Access | Times Cited: 14
The relationship between cannabis and cardiovascular disease: clearing the haze
Mark Chandy, Nerea Jimenez-Tellez, Joseph C. Wu
Nature Reviews Cardiology (2025)
Closed Access
Improvement in the Cognitive Function in Chronic Pain: Therapeutic Potential of the Endocannabinoid System
Saeideh Karimi‐Haghighi, Maryam Shaygan
Molecular Neurobiology (2025)
Closed Access
Transcriptomic Alterations Induced by Tetrahydrocannabinol in SIV/HIV Infection: A Systematic Review
Amir Valizadeh, Rebecca T. Veenhuis, Brooklyn Bradley, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2598-2598
Open Access
Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators
Paula Morales, Chanté Muller, Nadine Jagerovic, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 10
The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
Maria Sofia Basile, Emanuela Mazzon
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2986-2986
Open Access | Times Cited: 7
Fenchone Derivatives as a Novel Class of CB2 Selective Ligands: Design, Synthesis, X-ray Structure and Therapeutic Potential
Reem Smoum, Christeene Haj, Shira Hirsch, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1382-1382
Open Access | Times Cited: 6
Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy
Mona F. El-Azab, Ahmed E Wakiel, Yossef K Nafea, et al.
World Journal of Diabetes (2022) Vol. 13, Iss. 5, pp. 387-407
Open Access | Times Cited: 6
Effect of Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
Chitmandeep Josan, Tina Podinić, Nikko Pfaff, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0272819-e0272819
Open Access | Times Cited: 6
Motifs in Natural Products as Useful Scaffolds to Obtain Novel Benzo[d]imidazole-Based Cannabinoid Type 2 (CB2) Receptor Agonists
Analia Young Hwa Cho, Hery Chung, Javier Romero‐Parra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10918-10918
Open Access | Times Cited: 3
Role of the CB2 Cannabinoid Receptor in the Regulation of Food Intake: A Systematic Review
Luis Miguel Rodríguez–Serrano, María Elena Chávez–Hernández
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17516-17516
Open Access | Times Cited: 3
Differential Regulation of MMPs, Apoptosis and Cell Proliferation by the Cannabinoid Receptors CB1 and CB2 in Vascular Smooth Muscle Cells and Cardiac Myocytes
Bettina Greiner, Manuela Sommerfeld, Ulrich Kintscher, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3271-3271
Open Access | Times Cited: 5
The role of cannabinoid receptor 2 in bone remodeling during orthodontic tooth movement
Deng-ying Fan, Hao-yan Zhai, Yuan Zhao, et al.
BMC Oral Health (2024) Vol. 24, Iss. 1
Open Access
The Potential of JWH-133 to Inhibit the TLR4/NF-κB Signaling Pathway in Uterine Ischemia–Reperfusion Injury
Nihal İnandıklıoğlu, Taylan Onat, Kayode Yomi Raheem, et al.
Life (2024) Vol. 14, Iss. 10, pp. 1214-1214
Open Access
Activation of cannabinoid type 2 (CB2) receptors promotes the maintenance of redox homeostasis and protects against oxidative distress in the Neotropical freshwater fish matrinxã Brycon amazonicus (Characiformes: Bryconidae)
Suzana Luisa Alves Fernandes, Yan Costa Gonçalves, Francisco Tadeu Rantin, et al.
Neotropical Ichthyology (2024) Vol. 22, Iss. 4
Open Access
The synthetic cannabinoid agonist WIN 55,212-2 reduces experimental pruritus via CB2 receptor activation
A. Matthew Reck, David P. Siderovski, Steven G. Kinsey
Neuropharmacology (2024) Vol. 264, pp. 110216-110216
Closed Access
Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders
Calogera M. Simonaro, Makiko Yasuda, Edward H. Schuchman
Journal of Inherited Metabolic Disease (2024)
Open Access
Flipping the GPCR Switch: Structure–Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists
Erick M. Carreira, Miroslav Kosar, Roman C. Sarott, et al.
(2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top